sec filing
EN
OTC · ENZN
Enzon Pharmaceuticals, Inc.
Healthcare · Biotechnology
$4.71
Up+$0.06 (+1.29%)
Updated Aug 26, 2026, 2:09 PM
SID Score
5.0/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 4.08M
- P/E ratio
- -3.06
- Dividend yield
- 0.00%
- 52-week range
- $0.09 – $12.99
- Volume
- 1.58K
- Avg. volume
- 53.8K
Price performance
ENZN price history
1M range · 0 trading sessions · Daily adjusted prices
ENZN does not have enough price history for the selected period.
Data unavailable
The requested market data was not found.
Latest ENZN news
The latest Smart Investors Daily articles mentioning ENZN.
Stock researchCompany · Forecast
Loading stock research…